Felis consequat magnis est fames sagittis ultrices placerat sodales porttitor quisque.
In barely a decade, China has transformed from a maker of cheap generic copies of Western medicines into a global powerhouse of pharmaceutical innovation.
The country now only trails the United States in novel drugs under development, with a 29 per cent share, according to McKinsey. International pharmaceutical companies are beating a path to China’s shores to license next-generation treatments for cancer, autoimmune diseases and other disorders.
Government support, including regulatory and…
Media365Hong Kong’s sales of luxury homes more than doubled in the first quarter from a year earlier, helped by a buoyant stock market and attractively priced assets that drew the…
Media365A two-speed recovery is emerging in Central’s top-tier offices, prompting landlords to adopt a more hands-on leasing approach, including hiring asset managers, as rental performance diverges. While much attention has…
